First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and ce

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales

In a pooled self-controlled case series study, Steven Kerr and colleagues assess the association between first dose ChAdOx1 and BNT162b2 COVID-19 vaccination with cerebral venous sinus thrombosis in England, Scotland and Wales.

Related Keywords

Norway , United States , Belfast , United Kingdom , Denmark , Netherlands , Northern Ireland , Craigavon , Scotland , British , Oxford Astrazeneca Chadox , Laura Gonzalez Rienda , Maria Georgiou , Astra Zeneca , Vicky Hammersley , James Pickett , Wendy Inglis Humphrey , Suzannec Cannegieter , Oxford Astrazeneca , Dave Kelly , R Al Shahi Salman , Health Research Council , Administrative Data Research Wales , Development Division Welsh Government , United Kingdom Medical Research Council , Swansea University Medical School , United Kingdom Ltd , Department Of Health Northern Ireland , Research Scotland Senior Clinical Fellowship , Databank At Swansea University , Health Data Research Hub For Respiratory , Pfizer , Scientist Office , Astrazeneca , Department Of Health , Connectivity National Core Study , Public Health Agency Northern Ireland , Scientist Office Of The Scottish Government Health , Advisory Group , Wellcome , Innovation Industrial Strategy Challenge Fund , Services Partnership , Welsh Ambulance Service , United Kingdom Research , Scientific Pandemic Influenza Group On , National Institute For Health , Public Health Agency , Public Health Wales , Health Data Research United Kingdom , Office For National Statistics , Queen University Belfast , United Kingdom Scientific Advisory Group For Emergencies , Scientific Advisory Group On Emergencies , Community Health Index , Committee On Vaccination , Economic Research , Cardiff University , British Heart Foundation , Scottish Parliament , Swansea University Health Data Research United Kingdom , Scottish Government Expert Reference Group , Zealand Ministry For Business , Research Council , Technology Appraisal Committee , Risk Working Group , Mayo Clinic Health System , Sciences Research Council , United Kingdom Vaccine Effectiveness Expert Panel , Public Health Scotland , Leiden University Medical Center , European Medicines Agency , Care Research , Information Governance Review Panel , Wales Informatics Service , Coronavirus Disease , Creative Commons Attribution License , Swansea University , National Statistics , Medical Research Council , Health Data Research Hub , Respiratory Health , Health Data Research United , Kingdom Ltd , Physical Sciences Research Council , Social Research Council , Social Care , Chief Scientist Office , Scottish Government Health , Social Care Directorates , Social Care Research , Development Division , Welsh Government , Wales Institute , Scotland Senior Clinical Fellowship , Scottish Government Chief Scientist Office , Scottish Government Chief Medical Officer , Emerging Respiratory Virus Threats , Risk Stratification Subgroup , New Zealand Ministry , Scottish Government , Expert Reference Group , Scientific Advisory Group , Clinical Fellowship , Risk Working , National Institute , Care Excellence , Technology Appraisal , University Belfast , Scientific Pandemic Influenza Group , United Kingdom Scientific Advisory Group , Yearly Assessment , International Classification , Joint Committee , Observational Routinely Collected Data , European Economic Area , United Kingdom Wide , Shahi Salman , Welsh Government Technical Advisory Cell , Secure Anonymised Information Linkage , Informatics Service , Vaccination And Immunization , Medical Risk Factors , Covid 19 , Thrombosis , Vaccines , England , Wales ,

© 2025 Vimarsana